Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Hereditary angioedema (hae) – pipeline review, h1 2012


Published on || Hereditary Angioedema (HAE) – Pipeline Review, H1 2012 || Market Research

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

Hereditary angioedema (hae) – pipeline review, h1 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Hereditary Angioedema (HAE) – Pipeline Review, H12012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Hereditary Angioedema (HAE) - Pipeline Review, H1 2012,provides an overview of the Hereditary Angioedema (HAE) therapeutic pipeline.This report provides information on the therapeutic development for HereditaryAngioedema (HAE), complete with latest updates, and special features on late-stageand discontinued projects. It also reviews key players involved in the therapeuticdevelopment for Hereditary Angioedema (HAE). Hereditary Angioedema (HAE) -Pipeline Review, H1 2012 is built using data and information sourced from GlobalMarkets Direct’s proprietary databases, Company/University websites, SEC filings,investor presentations and featured press releases from company/university sitesand industry-specific third party sources, put together by Global Markets Direct’steam.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Hereditary Angioedema (HAE).- A review of the Hereditary Angioedema (HAE) products under development bycompanies and universities/research institutes based on information derived from
  2. 2. company and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.Table of contents:List of Tables 4List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Hereditary Angioedema (HAE) Overview 6Therapeutics Development 7An Overview of Pipeline Products for Hereditary Angioedema (HAE) 7Hereditary Angioedema (HAE) Therapeutics under Development by Companies 9Late Stage Products 10Comparative Analysis 10Mid Clinical Stage Products 11Comparative Analysis 11Pre-Clinical Stage Products 12Comparative Analysis 12Hereditary Angioedema (HAE) Therapeutics – Products under Development byCompanies 13Companies Involved in Hereditary Angioedema (HAE) Therapeutics Development14Pharming Group N.V. 14Dyax Corp. 15ViroPharma Incorporated 16Shire Plc 17BioCryst Pharmaceuticals, Inc. 18Hereditary Angioedema (HAE) – Therapeutics Assessment 19Assessment by Monotherapy Products 19Assessment by Combination Products 20Assessment by Route of Administration 21Assessment by Molecule Type 23
  3. 3. Drug Profiles 25RhC1INH - Drug Profile 25Product Description 25Mechanism of Action 25R&D Progress 25Rhucin - Drug Profile 26Product Description 26List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H1 2012 Review, H12012&PubId=&pagenum=1Hereditary Angioedema (HAE) – Pipeline Review, H1 2012Cataract – Pipeline Review, H1 2012Neurofibromatoses – Pipeline Review, H1 2012Viral Conjunctivitis – Pipeline Review, H1 2012Fistula – Pipeline Review, H1 2012
  4. 4. Onchocerciasis (River Blindness) – Pipeline Review, H1 2012Seborrhea – Pipeline Review, H1 2012Cerebral Palsy – Pipeline Review, H1 2012Hemolytic Disease In Newborns – Pipeline Review, H1 2012Panic Disorders – Pipeline Review, H1 20124SC AG – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: